Vancouver, BC – TheNewswire – May 25, 2021 – Solarvest BioEnergy Inc. (“Solarvest” or the “Company”) (TSXV: SVS), (“Solarvest” or the “Company”), announces that its Eversea TM Division Inc. has signed an agreement with MRF Associates Inc. to represent the company in Brazil. Under the agreement, MRF will leverage its extensive background and relationships to introduce SVS Organic Omega-3 products and ingredients to the Brazilian market.
MRF Associates Inc. (Principal, Dr. Michael Farley) has worked in the Brazilian healthcare sector since 2003. In the field of natural products, he advised Atrium Innovations (now Nestle) on the market entry for several large brands, on organized registration, sales and clinical studies for an animal feed nutraceutical and currently supports a manufacturer of dietary supplements from Sao Paulo in the procurement of CBD -Full spectrum oil tinctures. MRF is invested in a wellness clinic in Belo Horizonte that focuses on alternative treatments for chronic pain. In the 1990s, Michael led investment programs at Canada’s Foreign Ministry and was appointed Consul and Trade Commissioner in Milan, Italy. He received his PhD in philosophy of science from the Université de Montréal (1986).
Brazil (214 million inhabitants) is the 4th in the world th largest agricultural producer and an important market for vegetable organic matter. 70 million millennials (50% of the workforce) are driving the demand for these products . 2019 Data published by the minister It is Rio agriculture (MAPA) reports over $ 1 billion in organic sales, growing by $ 15 % per year a.
Consumer awareness of omega-3 products is high. The product range includes the supplement, functional food, natural products, vegan and wellness sectors. USDA organic imports are widespread in retail stores and online channels. “Brazil has a long history of herbal health products and medicines and is a significant market opportunity for SVS nutraceuticals,” says MRF. “We look forward to presenting the only omega-3 product from organic farming to retailers and manufacturers in all industries and to increasing our market share effectively and quickly.”
Consumer awareness of natural omega-3 products that are free of manufacturing chemicals, solvents, heavy metals and pollution is growing in the baby food market. Organic marketers recognize the value of contamination-free ocean plant-based production as a competitive advantage. The versatility of the patented ingredient has enabled the company to demonstrate that various organic omega-3 products can be integrated into existing marketing channels. In addition, in terms of intellectual property protection, intellectual property has been described as a rare commodity in this growing market segment.
SVS produces “Clean Label” products to meet the demand for high quality, plant-based organic omega-3 health products. The company also offers manufacturers and retailers “private” and “white” brands with our highly bioavailable omega-3 ingredient. Market research shows a strong demand for the unique properties of the product, especially among consumers who focus on organic and vegan diets. The company’s patented omega-3 active ingredient has been recognized by the FDA as an NDI (New Dietary Ingredient) and is USDA organic and EU organic certified.
Solarvest BioEnergy Inc. is an algae biologics company whose manufacturing platform offers an extremely flexible system capable of producing a wide range of products from omega-3s to omega-3s human therapeutic proteins. The company has successfully demonstrated the expression of BMP, a high quality therapeutic protein, viral antigens (immune stimulating proteins) and cecropins (antimicrobial peptide / protein). The company has initiated a program to express CBD and THC to be produced in GMP fermentation facilities.
For more information please contact:
Gerri Greenham, chairman of the board
Phone: (647) 204-4095
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Forward-looking information includes, among other things, statements regarding the terms of the offer, the closing of the offer and the expected use of the net proceeds received from the company. In general, forward-looking information can be identified by using forward-looking terminology such as “plans,” “expected,” “not expected,” “expected,” “budget,” “planned,” “estimates”. “Predicts,” “intends,” “anticipates,” or “does not anticipate” or “believes” or variations of such words and phrases or indicates that certain actions, events or outcomes “may,” “might,” “would,” ” could be “or is taken”, “occurs” or “achieved”. Forward-looking information is subject to known and unknown risks, uncertainties and other factors that could cause actual results, level of activity, performance, or performance of the company to differ materially from those expressed or implied by such forward-looking information, including but not limited to: general business, economic, competitive, geopolitical, and social uncertainties; and regulatory risks. While the company has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking information, there may be other factors that could cause results not to be as expected, estimated or intended . There can be no assurance that such information will prove to be accurate, as actual results and future events could differ materially from those anticipated in these statements. Accordingly, readers are cautioned not to place undue reliance on forward-looking information. The forward-looking information contained in this press release is expressly qualified in its entirety by this cautionary statement. The company does not undertake to update any forward-looking information unless required by applicable securities laws.
Neither the TSX Venture Exchange nor its regulator (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
None of Solarvest’s securities have been registered under the US Securities Act of 1933, as amended (the “US Securities Act”) or any state securities act, and may not be offered or sold in the United States or to or for the account or benefit by US persons or “US persons” (as that term is defined in Regulation S of the US Securities Act) without registration or exemption from such registration requirements. This press release does not constitute an offer to sell or the solicitation of an offer to buy in the United States, nor may any sale of the securities take place in any state in which such offer, solicitation or sale would be unlawful.
Copyright (c) 2021 TheNewswire – All rights reserved.